130 related articles for article (PubMed ID: 15829495)
1. Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients.
Etienne-Grimaldi MC; Pereira S; Magné N; Formento JL; Francoual M; Fontana X; Demard F; Dassonville O; Poissonnet G; Santini J; Bensadoun RJ; Szepetowski P; Milano G
Ann Oncol; 2005 Jun; 16(6):934-41. PubMed ID: 15829495
[TBL] [Abstract][Full Text] [Related]
2. Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.
Kharrat N; Al'Fadhli S; Rebaï A
J Recept Signal Transduct Res; 2008; 28(5):475-83. PubMed ID: 18946768
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.
Leite MS; Giacomin LC; Piranda DN; Festa-Vasconcellos JS; Indio-do-Brasil V; Koifman S; de Moura-Neto RS; de Carvalho MA; Vianna-Jorge R
BMC Cancer; 2014 Mar; 14():190. PubMed ID: 24629097
[TBL] [Abstract][Full Text] [Related]
5. EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.
Dubey S; Stephenson P; Levy DE; Miller JA; Keller SM; Schiller JH; Johnson DH; Kolesar JM;
J Thorac Oncol; 2006 Jun; 1(5):406-12. PubMed ID: 17409891
[TBL] [Abstract][Full Text] [Related]
6. Association of the EGFR intron 1 CA repeat length with lung cancer risk.
Zhang W; Weissfeld JL; Romkes M; Land SR; Grandis JR; Siegfried JM
Mol Carcinog; 2007 May; 46(5):372-80. PubMed ID: 17219440
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605
[TBL] [Abstract][Full Text] [Related]
8. An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.
Amador ML; Oppenheimer D; Perea S; Maitra A; Cusatis G; Iacobuzio-Donahue C; Baker SD; Ashfaq R; Takimoto C; Forastiere A; Hidalgo M
Cancer Res; 2004 Dec; 64(24):9139-43. PubMed ID: 15604284
[TBL] [Abstract][Full Text] [Related]
9. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
Precht C; Blessmann M; Kluwe L; Scheld T; Schön G; Henningsen A; Pflug C; Smeets R; Heiland M; Gröbe A
Eur J Oral Sci; 2017 Apr; 125(2):95-101. PubMed ID: 28150908
[TBL] [Abstract][Full Text] [Related]
10. No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer.
Lee SJ; Kim KM; Chae MH; Lee WK; Kam S; Cha SI; Han HS; Kim CH; Kang YM; Han SB; Park JY
Cancer Genet Cytogenet; 2007 Jan; 172(1):29-32. PubMed ID: 17175376
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of egfr Intron1 is associated with susceptibility and severity of asthma.
Wang X; Saito J; Ishida T; Munakata M
J Asthma; 2006 Nov; 43(9):711-5. PubMed ID: 17092854
[TBL] [Abstract][Full Text] [Related]
13. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.
Vashist YK; Trump F; Gebauer F; Kutup A; Güngör C; Kalinin V; Muddasar R; Vettorazzi E; Yekebas EF; Brandt B; Pantel K; Izbicki JR
Target Oncol; 2014 Mar; 9(1):43-52. PubMed ID: 23377570
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
[TBL] [Abstract][Full Text] [Related]
15. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism.
Liu W; Innocenti F; Chen P; Das S; Cook EH; Ratain MJ
Clin Cancer Res; 2003 Mar; 9(3):1009-12. PubMed ID: 12631599
[TBL] [Abstract][Full Text] [Related]
16. EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment.
Huang CL; Yang CH; Yeh KH; Hu FC; Chen KY; Shih JY; Lin ZZ; Yu CJ; Cheng AL; Yang PC
Lung Cancer; 2009 Jun; 64(3):346-51. PubMed ID: 18995924
[TBL] [Abstract][Full Text] [Related]
17. EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissues.
Zhou Q; Cheung YB; Jada SR; Lim WT; Kuo WL; Gray JW; Lee AS; Chowbay B
Cancer Biol Ther; 2006 Nov; 5(11):1445-9. PubMed ID: 17102595
[TBL] [Abstract][Full Text] [Related]
18. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
Han SW; Jeon YK; Lee KH; Keam B; Hwang PG; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Heo DS; Bang YJ; Kim TY
Pharmacogenet Genomics; 2007 May; 17(5):313-9. PubMed ID: 17429313
[TBL] [Abstract][Full Text] [Related]
19. R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome.
Gao LB; Zhou B; Zhang L; Wei YS; Wang YY; Liang WB; Lv ML; Pan XM; Chen YC; Rao L
BMC Med Genet; 2008 Jul; 9():74. PubMed ID: 18664296
[TBL] [Abstract][Full Text] [Related]
20. Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
Klinghammer K; Knödler M; Schmittel A; Budach V; Keilholz U; Tinhofer I
Clin Cancer Res; 2010 Jan; 16(1):304-10. PubMed ID: 20028750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
